Mehran M. Khodadoust, Ph.D. is the founder and Managing Director of Avexo Pharmaceuticals. With a distinguished background in science, he holds six degrees, including a Ph.D. in Immunobiology from Yale University. Dr. Khodadoust is a prolific innovator, credited as the inventor on 11 issued patents and over 30 filed patents. He began his career at Millennium Pharmaceuticals, where he led the discovery of several therapeutic targets. He co-founded Bionaut Pharmaceuticals, which was later acquired by BTG, and established VexO Pharmaceuticals in 2019, before founding Avexo Pharmaceuticals in 2024 to advance innovative therapeutics.